Reversal of Lipid-Induced Insulin Resistance
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT02193295
- Status
- Recruiting
Conditions
- Insulin Resistance
- NAFLD
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- Caloric Restriction — BEHAVIORALDietary intervention to reduce lipid content in liver and muscle with minimal overall weight loss. Weekly visits for measurements of body weight, body composition, blood glucose and MRS measurements of liver and muscle lipid.
Study Details
The purpose of this study is to examine whether weight reduction decreases intramyocellular (IMCL) and hepatic lipid content, and improves insulin sensitivity of muscle and fat tissue in people who are insulin resistant and have a family history of type 2 diabetes. Hepatic mitochondrial oxidation will be assesses using a 3 hour triple tracer study (D7 glucose, 3-13C lactate and 13C4 beta-hydroxybutyrate).
Key Dates
- Start date
- Oct 31, 2002
- Status verified
- May 2025
- Primary completion
- Oct 31, 2034
- Completion
- Dec 31, 2034
Study Design
- Enrollment
- 250 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Lifestyle InterventionCaloric Restriction to reverse lipid-induced insulin resistance.
- Experimental: Baseline Assessment of Hepatic Mitochondrial Fat OxidationTracer study to assess hepatic mitochondrial fat oxidation (PINTA).
Primary Outcome Measure
Improvements in insulin sensitivity [ Time Frame: up to 6 months intervention to examine whether insulin sensitivity has improved significantly after the moderate weight reduction ]
Central Contacts
- Kitt Petersen, MD203-785-5447
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Magnetic Resonance Research Center (MRRC) | New Haven | Connecticut | 06511 | - |
| Yale Center for Clinical Investigation HRU | New Haven | Connecticut | 06520 | Kitt Petersen, MD 203-688-4106 Kitt Petersen, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Haven, CT
Related Studies
- Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)Recruiting · Yale University · New Haven, Connecticut
- Digoxin In NASH (CODIN)PHASE2 · Recruiting · Yale University · New Haven, Connecticut
- New Mechanisms of ObesityRecruiting · Yale University · New Haven, Connecticut
- Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina